A detailed history of Spire Wealth Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Spire Wealth Management holds 7,309 shares of BSX stock, worth $657,810. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,309
Previous 2,679 172.83%
Holding current value
$657,810
Previous $206,000 197.09%
% of portfolio
0.02%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$72.96 - $84.0 $337,804 - $388,920
4,630 Added 172.83%
7,309 $612,000
Q2 2024

Jul 31, 2024

SELL
$67.33 - $77.71 $471 - $543
-7 Reduced 0.26%
2,679 $206,000
Q1 2024

Apr 24, 2024

BUY
$57.6 - $68.62 $30,528 - $36,368
530 Added 24.58%
2,686 $183,000
Q4 2023

Feb 06, 2024

SELL
$48.64 - $57.81 $56,130 - $66,712
-1,154 Reduced 34.86%
2,156 $124,000
Q3 2023

Nov 08, 2023

BUY
$50.19 - $54.68 $2,660 - $2,898
53 Added 1.63%
3,310 $174,000
Q2 2023

Aug 09, 2023

BUY
$49.72 - $54.64 $44,598 - $49,012
897 Added 38.01%
3,257 $176,000
Q1 2023

May 09, 2023

BUY
$45.09 - $50.03 $44,864 - $49,779
995 Added 72.89%
2,360 $118,000
Q4 2022

Feb 03, 2023

SELL
$39.56 - $47.22 $18,118 - $21,626
-458 Reduced 25.12%
1,365 $63,000
Q3 2022

Nov 07, 2022

SELL
$36.71 - $109.66 $34,177 - $102,093
-931 Reduced 33.81%
1,823 $71,000
Q2 2022

Jul 22, 2022

SELL
$35.24 - $47.1 $105 - $141
-3 Reduced 0.11%
2,754 $103,000
Q1 2022

Apr 18, 2022

SELL
$40.9 - $45.1 $55,787 - $61,516
-1,364 Reduced 33.1%
2,757 $122,000
Q4 2021

Jan 14, 2022

BUY
$38.07 - $44.87 $59,008 - $69,548
1,550 Added 60.29%
4,121 $175,000
Q3 2021

Oct 22, 2021

SELL
$41.23 - $45.88 $538,463 - $599,192
-13,060 Reduced 83.55%
2,571 $112,000
Q2 2021

Jul 26, 2021

SELL
$38.58 - $44.24 $109,142 - $125,154
-2,829 Reduced 15.33%
15,631 $668,000
Q1 2021

May 21, 2021

BUY
$35.27 - $39.67 $651,084 - $732,308
18,460 New
18,460 $713,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.